Vapotherm, Inc. Common Stock (NY:VAPO)

1.270 UNCHANGED

Last Price Updated: 7:00 PM EST, Dec 14, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vapotherm, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Benzinga's Top Ratings Upgrades, Downgrades For April 7, 2022 ↗

April 07, 2022

Upgrades

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

April 07, 2022

Gainers IMAC Holdings (NASDAQ:IMAC) shares increased by 60.0% to $1.6 during Thursday's pre-market session. The market value of their outstanding shares is at $41.9 million.

Via Benzinga

Vapotherm Issues Q1 FY22 Sales Guidance Below Expectations, Pulls FY22 Outlook ↗

April 07, 2022

Vapotherm Inc (NYSE: VAPO) expects

Via Benzinga

Recap: Vapotherm Q4 Earnings ↗

February 24, 2022

Vapotherm (NYSE:VAPO) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:10 PM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

February 23, 2022

On Wednesday, 348 companies hit new 52-week lows. Significant Points From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

April 07, 2022

We're diving into the biggest pre-market stock movers for Thursday that investors are going to want to keep track of today.

Via InvestorPlace

23 Stocks Moving in Thursday's Pre-Market Session ↗

April 07, 2022

Gainers HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) rose 46.7% to $1.88 in pre-market trading after the company announced it has harmonized its miRNA Whole Transcriptome...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

April 06, 2022

Gainers

Via Benzinga

Vapotherm Announces Preliminary Revenue for First Quarter of 2022 and Withdraws 2022 Annual Guidance

April 06, 2022

From Vapotherm, Inc.

Via Business Wire

Vapotherm Reports Fourth Quarter and Fiscal Year 2021 Financial Results

February 24, 2022

From Vapotherm, Inc.

Via Business Wire

Vapotherm to Report Fourth Quarter and Full Year 2021 Financial Results

February 10, 2022

From Vapotherm, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Thursday ↗

January 20, 2022

During Thursday's morning trading, 152 companies set new 52-week lows. Noteworthy Points From Today's 52-Week Lows: Rivian Automotive (NASDAQ:RIVN) was the largest...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

February 22, 2022

During Tuesday's trading, 505 companies set new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: The company with the largest market cap to...

Via Benzinga

Vapotherm Reports Preliminary Fourth Quarter and Full Year 2021 Revenue Results

January 12, 2022

From Vapotherm, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Friday ↗

February 18, 2022

On Friday, 313 companies hit new 52-week lows. Things to Consider About Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week...

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

February 17, 2022

On Thursday, 147 companies achieved new lows for the year. Significant Points From Today's 52-Week Lows: PayPal Holdings (NASDAQ:PYPL) was the biggest company...

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

January 19, 2022

During Wednesday's morning trading, 400 companies set new 52-week lows. 52-Week Low Highlights: Intuitive Surgical (NASDAQ:ISRG) was the largest company by...

Via Benzinga

Vapotherm to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference

November 22, 2021

From Vapotherm, Inc.

Via Business Wire

Vapotherm Reports Third Quarter 2021 Financial Results

November 03, 2021

From Vapotherm, Inc.

Via Business Wire

Vapotherm to Report Third Quarter 2021 Financial Results

October 20, 2021

From Vapotherm, Inc.

Via Business Wire

Looking Into Vapotherm's Return On Capital Employed ↗

September 14, 2021

Benzinga Pro data, Vapotherm (NYSE:VAPO) reported Q2 sales of $20.62 million. Earnings fell to a loss of $16.60 million, resulting in a 71.13% decrease from last quarter. In Q1,...

Via Benzinga

Earnings Scheduled For November 3, 2021 ↗

November 03, 2021

Companies Reporting Before The Bell • R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion....

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

September 08, 2021

Gainers Kadmon Holdings (NASDAQ:KDMN) shares increased by 72.64% to $9.15 during Wednesday's regular session. Trading volume for Kadmon Holdings's stock is 95.3...

Via Benzinga

Vapotherm Raises Annual Sales Outlook Amid Surge In COVID-19 Cases ↗

September 08, 2021

Vapotherm Inc (NYSE: VAPO) expects FY21 revenue of at least $102 million, an increase of $17 million over the low end of previous guidance of $85 million - $91...

Via Benzinga

Vapotherm Increases Fiscal Year 2021 Revenue Outlook and Announces Expansion of Production Capacity

September 08, 2021

From Vapotherm, Inc.

Via Business Wire

FDA Gives 510(K) Nod To Vapotherm's Next-Gen High-Velocity Therapy ↗

August 30, 2021

The

Via Benzinga

Vapotherm Announces FDA 510(k) Clearance for HVT 2.0 Next Generation Platform

August 30, 2021

From Vapotherm, Inc.

Via Business Wire

Vapotherm Reports Second Quarter 2021 Financial Results

August 09, 2021

From Vapotherm, Inc.

Via Business Wire

Vapotherm to Participate in the Canaccord Genuity 41st Annual Growth Conference

July 28, 2021

From Vapotherm, Inc.

Via Business Wire

Earnings Scheduled For August 9, 2021 ↗

August 09, 2021

Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million. •...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.